Marta Chuncia-Ileczko

Marta Chuncia-Ileczko

Auto-generated profile, based on publicly available information

Marta Chuncia-Ileczko

Central Teaching Hospital of the Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JKJulia Kulbacka
Julia Kulbacka
KDKarol Dziedzic
Karol Dziedzic
FAFilip Arczewski
Filip Arczewski
MWMichalina Wójcikiewicz
Michalina Wójcikiewicz
MCMarta Chuncia-Ileczko
Marta Chuncia-Ileczko
JRJulia Ryniecka
Julia Ryniecka
Background: The increasing popularity of ultra-endurance sports emphasizes the need for a deeper understanding of their health implications, particularly the impact on kidney function. Given the kidneys’ crucial role in waste filtration, fluid and electrolyte balance, and their close connection to the physiological demands of intense physical activity, it requires detailed investigation from this perspective. Purpose: The objective of this study is to present the current state of knowledge on the topic of kidney function in the context of ultra-endurance sports. It examines the risk factors, underlying mechanisms, and potential strategies for preventing renal injuries associated with these specific types of physical activities. Findings: Ultra-endurance sports present significant risks to kidney health, including acute kidney injury (AKI) estimated to affect approximately 40% of participants, rhabdomyolysis and dehydration, which are often compounded by additional factors such as gastrointestinal distress and the use of non-steroidal anti-inflammatory drugs (NSAIDs). There is a need for improved diagnostic criteria to detect acute renal injury in this population, with novel biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and cystatin C showing promise. A multifaceted preventive approach including strategies such as mandatory pre-event screening, the use of personal monitoring devices, proper hydration and nutrition, adequate race preparation, and the avoidance of NSAIDs is crucial to mitigate these risks and maintain renal health in ultra-endurance athletes.

5 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MWMaciej Wojszczyk
Maciej Wojszczyk
JKJulia Kulbacka
Julia Kulbacka
KDKarol Dziedzic
Karol Dziedzic
FAFilip Arczewski
Filip Arczewski
MWMichalina Wójcikiewicz
Michalina Wójcikiewicz
JRJulia Ryniecka
Julia Ryniecka
LADA (latent autoimmune diabetes in adults) is a dual form of diabetes, combining the autoimmune features typical of type 1 diabetes and the clinical and metabolic aspects of type 2 diabetes. Due to the slow development of symptoms and often late age of onset, LADA is frequently misdiagnosed as type 2 diabetes, which can lead to a delay in appropriate treatment. It is estimated that LADA affects between 4% and 12% of adults initially diagnosed with type 2 diabetes, making it a more common disease entity than previously thought. This paper examines current data on the epidemiology, pathogenesis, genetic factors and diagnostic criteria of LADA. Particular attention was given to the immunological and genetic aspects of the disease, which allow a more accurate differentiation of LADA from type 2 diabetes. The review also discusses the significance of early insulin therapy aimed at beta-cell preservation and the role of alternative treatments, such as DPP-4 inhibitors, which may influence disease progression. Diagnostic and therapeutic challenges stemming from the phenotypic similarities between LADA and type 2 diabetes are highlighted, along with potential benefits of early detection.

10 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
WCWitold Czyż
Witold Czyż
MCMarta Chuncia-Ileczko
Marta Chuncia-Ileczko
MWMichalina Wójcikiewicz
Michalina Wójcikiewicz
FAFilip Arczewski
Filip Arczewski
KDKarol Dziedzic
Karol Dziedzic
JRJulia Ryniecka
Julia Ryniecka
Over the past 50 years, a substantial body of research revealed an association between Epstein-Barr virus (EBV), and various aspects of EBV infection, with multiple autoimmune diseases. Growing evidence points to EBV as a potential co-factor in systemic lupus erythematosus (SLE) and several mechanisms have been proposed to explain this relationship, however there is as yet no conclusive proof of causality. This literature review constitutes an introduction into the subject and attempts to outline the findings on the EBV-SLE connection, focusing mostly on the evidence provided by serological studies.

5 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DZDamian Zys
Damian Zys
MWMaciej Wojszczyk
Maciej Wojszczyk
JRJulia Ryniecka
Julia Ryniecka
WCWitold Czyż
Witold Czyż
JKJulia Weronika Kacperczyk
Julia Weronika Kacperczyk
JKJulia Kulbacka
Julia Kulbacka
Introduction: Myocarditis is an inflammatory disease of the heart muscle, presenting with symptoms ranging from mild discomfort to severe cardiac dysfunction. It poses diagnostic challenges due to overlap with conditions such as coronary artery disease and its nonspecific presentation. This review summarizes current diagnostic and therapeutic approaches, emphasizing advancements in imaging and personalized treatment strategies. Aim of the study: The aim of this study was to summarize the existing knowledge of currently relevant diagnostic and therapeutic approaches to myocarditis, highlighting both established methods and emerging advances. Materials and Methods: The literature available in the PubMed database was reviewed using the following keywords: "myocarditis," "myocarditis diagnosis," "myocarditis treatment," "diagnosis of myocarditis," "COVID-19 myocarditis," "viral myocarditis," and "autoimmune myocarditis." Conclusions: Myocarditis is a complex and multifactorial condition that requires improved diagnostic tools and individualized treatment strategies. As with other diseases, personalized approaches considering patient-specific factors are essential for better clinical outcomes. To achieve this, further research into innovative diagnostic methods and targeted therapies is necessary. Additionally, raising awareness of myocarditis is crucial for early diagnosis, timely treatment, and patient support.

6 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MCMarta Chuncia-Ileczko
Marta Chuncia-Ileczko
WCWitold Czyż
Witold Czyż
JKJulia Weronika Kacperczyk
Julia Weronika Kacperczyk
FAFilip Arczewski
Filip Arczewski
KDKarol Dziedzic
Karol Dziedzic
JRJulia Ryniecka
Julia Ryniecka
Background: Sex hormones have a key impact on the development of the human body during puberty, including a significant influence on bone development - their shape, structure, length, and mineral density. Due to the growing number of transgender and gender diverse (TGD) adolescents and the increasing demand for gender-affirming hormone therapy (GAHT), there is rising curiosity about the impact of this therapy on the developing body of a young person. Purpose: This review aims to summarize the latest scientific reports on the impact of gonadotropin-releasing hormone analogues (GnRHas) and GAHT on the bone mineral density (BMD) of transgender adolescents undergoing gender-changing therapies. Findings: Low pretreatment BMD is more common among TGD adolescents than in the general population, and this is more prevalent in transgirls than in transboys. BMD Z-scores decline during treatment with GnRHas and respond differentially to GAHT. Regular follow-up and health advice are essential. Further long-term studies of the effects of these therapies on peak bone mass and future fracture risk are needed.

31 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JRJulia Ryniecka
Julia Ryniecka
MWMaciej Wojszczyk
Maciej Wojszczyk
DZDamian Zys
Damian Zys
PPPiotr Pasek
Piotr Pasek
JKJulia Kulbacka
Julia Kulbacka
KDKarol Dziedzic
Karol Dziedzic
Thyroid eye disease (TED) is a challenging autoimmune disorder that often requires therapeutic intervention. Glucocorticoids (GCs), particularly in intravenous (IV) regimens, remain the first-line treatment due to their strong anti-inflammatory and immunosuppressive effects. This paper focuses on the efficacy, protocols, and safety profiles of selenium supplementation and glucocorticoid therapy, emphasizing its central role in TED management. Alternative therapies, such as teprotumumab, rituximab, and tocilizumab, are briefly discussed as potential options for patients with moderate-to-severe TED, who are unresponsive or intolerant to glucocorticoids. Adherence to recommended dosing protocols and careful monitoring of adverse effects are essential to optimize treatment outcomes.